Digital Factory Delivery Manager at Acadia Pharmaceuticals

Lisbon, Lisbon, Portugal

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, ManufacturingIndustries

Requirements

  • Bachelor’s in Engineering, Computer Science, or related field (Master’s is a plus)
  • 5+ years in manufacturing and digital transformation
  • Strong project management and stakeholder engagement skills
  • Knowledge of SAP S/4 (PP, PP-PI, Plant Maintenance), MES, OT software (OPC, Historians)
  • Familiarity with IT infrastructure and validation standards (e.g., GAMP)
  • Fluent in English (French or Portuguese is a plus)

Responsibilities

  • Lead IT/OT teams across multiple sites in a matrix setup
  • Coordinate digital demands from ideation to implementation
  • Build strong relationships with site leaders and global stakeholders
  • Oversee deployment of digital tools to optimize manufacturing
  • Monitor KPIs and drive continuous improvement
  • Manage OPEX and CAPEX budgets aligned with strategic goals
  • Ensure compliance with global technology standards
  • Collaborate with global functions (ERP, Analytics, Infra, etc.)

Skills

SAP S/4
PP
PP-PI
Plant Maintenance
MES
Project Management
Stakeholder Engagement
Digital Transformation
IT/OT
ERP
Analytics

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI